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Many women take supplemental estrogens after menopause, a practice called hormone 
replacement therapy (HRT). Moderate alcohol consumption may increase estrogen levels in 
women receiving HRT, potentially affecting their risk for various adverse health effects. Two 
recent studies, however, provide no strong evidence for an effect of alcohol on hormones in 
postmenopausal women. The possible association between alcohol consumption and risk of 
cancer of the breast does not appear to be mediated by estrogens. Both estrogens and 
moderate alcohol consumption have been associated with a decreased risk for cardiovascular 
disease; however, alcohol’s beneficial effect on heart disease does not appear to involve 
hormonal mechanisms. Additional research is needed to define the consequences of 
moderate drinking on hormone levels after menopause. KEY WORDS: AODE (alcohol and other 
drug effects); menopause; female; sex hormones; estrogens; mammary gland; neoplastic 
disease; cardiovascular disorder; moderate AOD use; drug therapy; literature review 
American women are older A
pproximately 30 percent of unpleasant symptoms of menopause, play important roles in the meno-
a practice called hormone replacement pausal transition, this article focuses 
than age 50, the average therapy (HRT) (Ginsburg et al. 1996). on estrogens, in part because the health 
age of menopause (Cramer Estrogens have various effects on the effects of altered estrogen levels are 
and Xu 1996).1 Epidemiological health of postmenopausal women relatively well understood. For a dis-
studies suggest that approximately 50 (Rich-Edwards and Hennekens 1996). cussion of alcohol’s effects on post-
percent of women in this age group For example, HRT decreases the risk menopausal women with alcoholic 
consume at least moderate quantities of cardiovascular disease and osteo- cirrhosis, see Gavaler (1995). 
of alcohol (National Institute on porosis4 but may increase the risk of 
Alcohol Abuse and Alcoholism breast cancer (Ginsburg et al. 1996). 
[NIAAA] 1997).2 Therefore, any Recent experimental studies show 1The article cited defines menopause as the 
absence of menstrual periods for 1 year (Crameradverse effects of alcohol among this that moderate alcohol consumption 
and Xu 1996).population could have a significant may increase estrogen levels in post-
effect on public health. menopausal women receiving HRT	 2Although definitions of moderate drinking vary 
widely, an upper limit of two standard drinks perMenopause is characterized by (Ginsburg et al. 1996). 
day for men and one for women is often employed.greatly diminished levels3 of a group This article reviews some of the A standard drink is equivalent to 12 ounces of
of steroid reproductive hormones basic hormonal changes associated beer, 5 ounces of wine, or 1.5 ounces of 80-proof 
called estrogens. Estrogens (e.g., with menopause, examines the effects spirits (NIAAA 1992). 
estrone and estradiol) travel through of alcohol consumption on estrogen 3Unless otherwise specified, this article uses the
the bloodstream and exert widespread levels after menopause, and discusses term “level(s)” to refer to the concentrations of 
physiological effects on organ growth the relationship of postmenopausal a given substance in the blood. 
and development. Approximately 25 alcohol use to the risks of cardio­ 4Osteoporosis is a bone disorder that commonly
percent of postmenopausal women take vascular disease and cancer. Although occurs in postmenopausal women (see article by 
supplemental estrogens to alleviate several reproductive hormones may Sampson and colleagues, pp. 190–194). 
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 Hormonal Function 
Before Menopause 
The female reproductive cycle is 
governed primarily by two groups 
of hormones: the gonadotropins and 
the steroid reproductive hormones. 
The gonadotropins include follicle-
stimulating hormone (FSH) and 
luteinizing hormone (LH), which are 
produced by the pituitary gland and 
released into the bloodstream. The 
steroid reproductive hormones are pro­
duced largely in the ovaries. Approx­
imately every 28 days, levels of FSH 
and LH in the blood begin to increase, 
stimulating the growth and develop­
ment of specialized cell clusters (i.e., 
follicles) within the ovaries. Each 
follicle nurtures a developing egg 
cell (i.e., ovum) and secretes estrogens. 
Within the ovaries, estrogens help 
promote follicular development. A 
midcycle surge of LH secretion from 
the pituitary gland causes the release 
of a mature ovum, which then migrates 
away from the ovaries. Under the 
influence of LH, the ovary continues 
to secrete estrogens and other steroid 
hormones to prepare the body for 
pregnancy and lactation. If the ovum 
is not fertilized, gonadotropin and 
ovarian hormone levels decline until 
the next cycle is about to begin. 
These cyclic events are orchestrated 
by complex interactions among 
many hormones and other physiolog­
ical substances. For example, the ovaries 
release hormones called activin and 
inhibin, which, respectively, stimulate 
and suppress gonadotropin produc­
tion. In addition, the pituitary gland 
adjusts the magnitude and timing of 
gonadotropin secretion in response 
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to levels of ovarian hormones in the 
blood. This mechanism, called feed­
back regulation, helps fine tune 
hormone levels and promotes the 
orderly progression of physiological 
events. Hormonal balance also is 
influenced by metabolic reactions 
that can synthesize specific hormones 
from other hormones to which they 
are structurally related. 
Hormonal Changes 
During Menopause 
The number of functional ovarian fol­
licles decreases with age. This decrease 
accelerates after approximately age 40 
(Burger 1996a); thus, by the time a 
woman experiences her final men­
strual period (i.e., menopause), the 
ovaries contain virtually no follicles 
(Burger 1996b). The postmenopausal 
state is characterized by unvarying 
hormone levels and the absence of 
ovulatory cycling. 
The approach of menopause is 
signaled by a transitional period that 
begins with a break in the regular 
pattern of ovarian cycling. During 
the transitional phase, which lasts 
approximately 4 years, hormone 
levels fluctuate widely. In particular, 
FSH levels sometimes increase signif­
icantly, even in the presence of normal 
ovarian function and without an 
accompanying decrease in estradiol 
levels (Metcalf et al. 1981). Although 
overall levels of estradiol and inhibin 
change relatively little during the 
transitional phase (Korenman et al. 
1978; Burger 1996b), subtle declines 
in their levels may contribute to 
the progressive elevation of FSH to 
consistently high postmenopausal 
levels (see next section of this article) 
(Burger 1996b). 
Hormones in 
Postmenopausal Women 
Despite the absence of ovarian folli­
cles, estrogen production continues 
after menopause, albeit at reduced 
levels. Postmenopausal estrogens are 
synthesized from a class of steroid 
hormones called androgens (e.g., 
testosterone and androstenedione). In 
men, androgens are the primary repro­
ductive hormones, produced mainly 
in the testes. In women, androgens 
are produced in the ovaries and in 
the adrenal glands and are carried 
through the bloodstream to body fat, 
where androstenedione is converted 
to estrone (Korenman et al. 1978). 
After menopause, estrone replaces 
estradiol as the primary estrogen 
(Korenman et al. 1978). Postmeno­
pausal estradiol levels are greatly 
reduced and are derived from the 
metabolism of estrone (Korenman et 
al. 1978; Burger 1996a). 
Levels of testosterone and ovarian 
androstenedione also decrease after 
menopause, although adrenal andro­
stenedione levels remain unchanged 
until later in life (Burger 1996a). 
Inhibin levels become undetectable 
after menopause (Burger 1996b). 
Released from the feedback regulation 
formerly provided by changing levels 
of ovarian hormones, levels of FSH 
increase up to 15 times compared with 
premenopausal levels, and LH levels 
increase up to 3 times (Burger 1996b); 
the significance of these increases in 
the absence of ovarian follicles is 
probably minimal. 
Alcohol and Estrogen 
Levels 
Studies of alcohol’s effects on post­
menopausal women generally focus 
on estradiol because of its greater 
potency compared with estrone. 
However, the low levels of estradiol 
after menopause are difficult to mea­
sure accurately (Carlstrom 1996). 
Methods for quantifying steroids 
differ in sensitivity and specificity, 
a factor that may contribute to the 
discrepancies in analytical results 
among studies (Gavaler et al. 1991; 
Cauley et al. 1989). 
In one study, a single large dose 
of alcohol (42 to 46 grams, equivalent 
to approximately 3.5 to 4 standard 
drinks) caused a temporary increase 
in estradiol levels in postmenopausal 
women receiving HRT (Ginsburg et 
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al. 1995, 1996) (see table 1), possibly 
by inhibiting the conversion of estra­
diol to estrone. However, alcohol 
administration had no effect on hor­
mone levels in women who were not 
receiving HRT. This result is consis­
tent with an earlier finding that 
alcohol administration under similar 
conditions had no effect on LH levels 
in postmenopausal women regardless 
of HRT use (Mendelson et al. 1985). 
In addition, alcohol administration 
had no effect on estrone levels in 
either group of women. The effects of 
lower doses or prolonged administra­
tion of alcohol have not been studied 
experimentally. 
In nonexperimental studies, 
researchers have compiled epidemio­
logical data to investigate possible 
associations between self-reported 
alcohol consumption and hormone 
levels among postmenopausal women 
(see table 2). Alcohol consumption 
was consistently unrelated to estrone 
levels in those studies. Findings for 
estradiol were mixed among women 
not on HRT, with some studies show­
ing a direct association between 
alcohol consumption and estradiol 
levels and some not. In contrast to 
the results summarized in table 1, 
nonexperimental data on women 
receiving HRT (Johannes et al. 1997) 
found lower levels of estradiol among 
women who consume higher levels 
of alcohol (table 2). 
Additional data suggest that alco­
hol consumption after menopause is 
unrelated to levels of androstenedione, 
(Cauley et al. 1989), testosterone 
(Cauley et al. 1989; Newcomb et al. 
1995), or sex hormone-binding 
globulin, a specialized protein that 
facilitates the transport of androgens 
through the bloodstream (Newcomb 
et al. 1995; Nagata et al. 1997). How­
ever, two of three studies demonstrated 
an association between alcohol con­
sumption and levels of a specific 
steroid substance that serves as an 
intermediary for the synthesis of 
androstenedione (Nagata et al. 
1997; Barret-Conner and Goodman-
Gruen 1995; Newcomb et al. 1995). 
The only study that examined alco­
hol’s effects on estrone sulfate found 
a positive association between alco­
hol consumption and estrone sul­
fate levels (Hankinson et al. 1995). 
Together, these data suggest that 
alcohol may affect hormones other 
than the major estrogens. However, 
confirmations of those associations 
are needed before any firm conclusions 
can be drawn. 
The epidemiological studies 
described above address only the 
overall association between alcohol 
consumption and hormone levels. 
Little information is available on 
specific factors that might modify 
or contribute to alcohol’s effects. 
Those factors might include drinking 
patterns, including timing, frequency, 
Table 1 Effect of a Single Dose of Alcohol on Estrogen Levels in the Blood of Postmenopausal Women 
Result 
Author n Ethanol Dose (g) E1 E2 Subjects on Hormone Replacement Therapy 
Ginsburg et al. 1995 7 46 no change increased yes 
Ginsburg et al. 1996 12 42 no change increased yes 
12 42 no change no change no 
NOTE: n = number of subjects; g = grams; E1 = estrone; E2 = estradiol. 
Table 2 The Relation of Alcohol Consumption to Estrogen Levels in the Blood of Postmenopausal Women 
Result 
Author n E1 E2 Subjects on Hormone Replacement Therapy 
Cauley et al. 1989 1761 no change no change past or never 
Newcomb et al. 1995 253 no change — never 
Hankinson et al. 1995 217 no change no change past or never 
Johannes et al. 1997 148 no change no change past 
53 no change no change never 
92 no change decreased yes 
Gavaler et al. 1991 244 — increased2 past or never 
Nagata et al. 1997 61 — increased past or never 
NOTE: n = number of subjects; E1 = estrone; E2 = estradiol; — = not measured or data not given. 
1Note that 128 of the subjects were in the Pittsburgh subgroup of Gavaler et al. 1991. 
2E2 increased in subjects from three of four cities studied. 
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and quantity of consumption; the time 
that has elapsed between a subject’s 
last drink and the determination of her 
hormone levels; and alcohol’s ultimate 
effects on the tissue responses induced 
by specific hormones. Additional data 
also are needed on the effects of alco­
hol on the adrenal steroid hormone 
precursors of estrogens and on estrone 
sulfate. In addition, most of the sub­
jects in the studies cited who con­
sumed alcohol were light or moderate 
drinkers (i.e., consuming approxi­
mately two to four drinks per week); 
thus, the available data provide little 
information about the effect of heavy 
drinking. Results also are subject to 
errors in the estimation of alcohol 
consumption and imprecision in the 
determination of hormone levels. 
Overall, the data in tables 1 and 2 
are consistent with the hypothesis that 
light or moderate alcohol consump­
tion does not affect estrone levels. In 
addition, although data from some 
nonexperimental studies have linked 
alcohol consumption with higher levels 
of other steroid hormones in post­
menopausal women (e.g., estradiol 
and estrone sulfate), the evidence that 
alcohol affects the levels of those hor­
mones is inconclusive. 
Alcohol, Hormones, 
and Cancer 
Cancer of the breast is among the 
most common fatal cancers among 
women in the United States. Annually, 
approximately 180,000 women are 
diagnosed with breast cancer, and 
44,000 women die of the disease (Chu 
et al. 1996). Evidence suggests that 
alcohol consumption may be associated 
with increased risk for this cancer, 
although whether this association is 
causal remains unresolved (Longnecker 
1992). The lack of strong evidence for 
alcohol-induced changes in estrogen 
levels either before or after menopause 
suggests that effects of alcohol in 
breast cancer may involve nonhor­
monal mechanisms. This conclusion 
is supported by evidence suggesting 
that alcohol consumption is not a risk 
factor for cancer of the glandular 
internal lining of the uterus (i.e., 
endometrial cancer), which is known 
to be hormone related (Rich-Edwards 
and Hennekens 1996). In the mam­
mary glands of rats, alcohol caused 
tissue changes thought to be associ­
ated with increased risk for cancer 
without affecting estrogen levels 
(Singletary 1997). 
Alcohol, Hormones, 
and Heart Disease 
Among women, consumption of 
at least one standard drink per day 
is associated with approximately a 
20-percent reduction in risk of 
cardiovascular disease compared with 
nondrinkers (Thun et al. 1997). 
Although the nature of this relation­
ship is the subject of continuing 
debate (Lowenfels 1998), evidence 
shows that moderate alcohol consump­
tion ameliorates known risk factors 
for cardiovascular disease, including 
specific measures of blood chemistry 
and the clotting response (Freedman 
et al. 1992; Kannel and Ellison 1996). 
Estrogens have a beneficial effect on 
risk for cardiovascular disease, and 
most cardiovascular disease in women 
occurs after menopause, when estro­
gen levels are low (Witteman et al. 
1998). Lack of a clear effect of alcohol 
on estrogens in postmenopausal women, 
however, does not preclude a causal 
relation between light and moderate 
intake and decreased risk of cardiovas­
cular disease. (See the article by 
Gavaler on pp. 220–227 for another 
view on this topic.) 
Summary 
The complete loss of ovarian follicles 
among middle-aged women is nor­
mal, and after menopause, estrogen 
levels are low. In general, the few 
studies available provide no strong 
evidence for an effect of alcohol on 
hormones in postmenopausal women. 
In addition, the possible association 
between alcohol consumption and 
risk of breast cancer does not appear 
to be mediated by estrogens. Evidence 
supports an association between mod­
erate alcohol consumption and a 
decreased risk of cardiovascular disease, 
and this effect may be independent 
of hormonal influence. More data 
are needed to confirm these findings 
and to clarify the roles and relative 
importance of alcohol both during 
and after menopause on hormones 
other than estrogens. ■ 
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How effective is brief intervention for helping patients 
to reduce or stop drinking? 
What strategies can be used in the workplace to prevent 
and reduce alcohol-related problems? 
T he answers to these and other questions can be found in Alcohol Alert, the quarterly bulletin published by the National Institute on Alcohol Abuse and Alcoholism. Alcohol Alert provides timely information on alcohol research and treatment. Each issue addresses a specific topic in alcohol research and 
summarizes critical findings in a brief, four-page, easy-to-read format. Our most recent issue — Brief 
Intervention for Alcohol Problems (No. 43)—explains the components of brief intervention and considers 
the effectiveness of this approach. 
Forthcoming issues include the following: 
•	 Alcohol and the Workplace (No. 44), which discusses recent research on the effects of
 
employee drinking, workplace alcohol policies, and workplace-based programs for 

preventing and reducing alcohol-related problems.
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